Pharmaids Pharmaceuticals Ltd

Pharmaids Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Pharmaids Pharmaceuticals Ltd

₹ 28.6 3.36%
01 Apr - close price
pharmaids.com BSE: 524572
About

Incorporated in 1989, Pharmaids Pharmaceuticals Ltd manufactures Bulk Drugs and Intermediaries.

Key Points

Product Portfolio:
a) Specialty Chemicals:[1] Retinol, DL Alpha Tocopherol, D-Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10, D-Biotin
b) Skin Care:[2] Best care hands, Hands Sanitizer, Moisturizing Cream, Skin-Sure Plus, Skin-Sure Ultra, Alcohol Gel, Barrier Cream
c) Hospital Care:[3] Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen-G, Strumen TRIACID, Facein Eco, Facein Power, Facein Spray, Sod Hypochlorite, Wipes, PPE
d) Generics:[4] Linzomust, Ceforoot 1.5g, Trendyclav-L, Cobasure Gold 2ML INJ, Benfoshine, Amplimmune, Thiaxa T8, Molprime SR, Citibrain-Plus, Duojoint

Website BSE
  • Market Cap ₹ 101 Cr.
  • Current Price ₹ 28.6
  • High / Low ₹ 73.4 / 27.1
  • Stock P/E
  • Book Value ₹ 14.7
  • Dividend Yield 0.00 %
  • ROCE -17.4 %
  • ROE -16.3 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 33.0%
  • Company has a low return on equity of -20.0% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
0.00 0.00 0.00 0.00 0.02 5.81 4.73 5.24 4.71 4.77 6.66 8.61 5.43
0.69 8.60 1.61 1.02 2.45 11.39 8.14 7.65 7.60 8.67 12.03 13.93 7.94
Operating Profit -0.69 -8.60 -1.61 -1.02 -2.43 -5.58 -3.41 -2.41 -2.89 -3.90 -5.37 -5.32 -2.51
OPM % -12,150.00% -96.04% -72.09% -45.99% -61.36% -81.76% -80.63% -61.79% -46.22%
0.00 0.00 0.41 -0.26 0.76 0.12 -0.07 0.08 0.00 0.13 0.04 3.03 -0.32
Interest 0.00 0.00 0.00 0.00 0.02 0.77 0.26 0.33 0.48 1.01 1.20 0.93 0.72
Depreciation 0.01 0.00 0.01 0.01 0.04 0.63 0.57 0.61 0.64 0.62 0.61 0.47 0.48
Profit before tax -0.70 -8.60 -1.21 -1.29 -1.73 -6.86 -4.31 -3.27 -4.01 -5.40 -7.14 -3.69 -4.03
Tax % 0.00% -28.37% 7.44% -60.47% -33.53% -7.73% -27.38% -30.58% -24.94% -11.11% -26.05% -30.62% -34.24%
-0.71 -6.16 -1.30 -0.50 -1.15 -6.33 -3.12 -2.27 -3.01 -4.80 -5.27 -2.57 -2.65
EPS in Rs -0.54 -2.87 -0.61 -0.23 -0.54 -1.57 -0.76 -0.55 -0.55 -1.12 -1.39 -0.71 -0.70
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
4 0 15 19 25
4 10 27 32 43
Operating Profit 0 -10 -12 -13 -17
OPM % 3% -82% -66% -67%
0 0 0 0 3
Interest 0 0 2 2 4
Depreciation 0 0 2 2 2
Profit before tax 0 -10 -16 -17 -20
Tax % 0% -24% -24% -22%
0 -8 -12 -14 -15
EPS in Rs 0.15 -3.52 -2.26 -3.06 -3.92
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 70%
TTM: 24%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -36%
Stock Price CAGR
10 Years: 18%
5 Years: 20%
3 Years: 9%
1 Year: -59%
Return on Equity
10 Years: %
5 Years: %
3 Years: -20%
Last Year: -16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 10 21 35 35 35
Reserves -2 1 37 24 17
0 0 9 39 20
2 2 11 22 26
Total Liabilities 11 25 91 120 98
0 0 63 77 55
CWIP 0 2 7 5 3
Investments 0 3 0 0 0
11 19 21 39 41
Total Assets 11 25 91 120 98

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0 -4 -11 -14
0 -5 -75 -12
0 21 78 23
Net Cash Flow 0 12 -8 -3
Free Cash Flow -0 -6 -33 -26
CFO/OP -200% 41% 86% 109%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 124 65 59
Inventory Days 91 0 112 359
Days Payable 236 159 480
Cash Conversion Cycle -21 17 -63
Working Capital Days -18 -69 -160
ROCE % -64% -26% -17%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Capital Work-in-Progress (Standalone)
INR Lakhs ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Electricity Consumption
Units (KWH) ・Standalone data
Number of Permanent Employees
Number ・Standalone data
Land Assets (Manufacturing/R&D)
Acres ・Standalone data
GLP Certified Research Facilities
Number

Shareholding Pattern

Numbers in percentages

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
9.95% 9.94% 9.70% 9.25% 5.64% 5.56% 5.19% 5.22% 5.22% 5.14% 32.99% 32.99%
90.05% 90.07% 90.31% 90.75% 94.36% 94.44% 94.81% 94.79% 94.78% 94.87% 67.00% 67.01%
No. of Shareholders 7,7617,4767,3937,2817,5677,5948,0498,3498,2208,0268,0278,288

Documents

Announcements

Annual reports